Using a mouse model of rheumatoid arthritis, scientists have discovered that a form of cellular immunotherapy by intravenous administration of monocytic myeloid-derived suppressor cells ...

The intravenous administration of monocytic myeloid-derived suppressor cells, or M-MDSCs, proved promising in treating rheumatoid arthritis in mice, inhibiting T cell proliferation, as well as B ...

The researchers analyzed three rheumatoid arthritis growth factors in mouse models and identified the signaling protein GM-CSF as the most promising for potential protective benefit against ...

WASHINGTON (HealthDay News) -- Researchers believe they've developed an important new tool in understanding rheumatoid arthritis: a genetically altered mouse that closely mimics the disease in humans.

Injections of these nanosponges effectively treated severe rheumatoid arthritis in two mouse models. Administering ... This work is one of the latest examples of therapeutic nanosponges developed ...

One group was treated with control solution and the other group was treated with M-MDSCs isolated from mouse donors with arthritis. All mice received five treatments through intravenous injections.